(SPNS) Sapiens International - Ratings and Ratios

Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: KYG7T16G1039

SPNS: Software, Solutions, Insurance, Technology, Platforms, Systems

Sapiens International Corporation N.V. (NASDAQ: SPNS) is a leading global provider of software solutions tailored for the insurance industry, serving clients across North America, the UK, Europe, the Middle East, Africa, Asia Pacific, and other international markets. The company specializes in delivering comprehensive platforms for property and casualty (P&C) insurance, both commercial and personal lines, as well as life and pensions, and reinsurance sectors.

Among its key offerings is the IDITSuite, an AI-driven, end-to-end insurance software solution designed to streamline operations and enhance efficiency. The company also provides DigitalSuite, a cloud-native platform focused on digital engagement and future-proofing insurance businesses. Additionally, Sapiens offers IDITGo, a pre-configured solution that accelerates insurance product launches with enriched data capabilities. For P&C commercial lines, the company delivers consultancy services, complementing its technology offerings with expert insights and strategic guidance.

The company’s product portfolio extends to CoreSuite, an end-to-end cloud and digital policy administration system (PAS) supporting individual and group products across life, health, wealth, and pensions. CustomerConnect provides dynamic self-service portals for insureds, while AgentConnect serves as a dedicated platform for agents and brokers, focusing on sales enablement, customer retention, and value enhancement. ReinsuranceMaster rounds out their offerings, delivering automation software that grants insurers full financial control and flexibility over reinsurance processes.

Founded in 1982 and headquartered in Holon, Israel, Sapiens has established itself as a trusted partner in the insurance software sector. The company’s solutions are designed to address the evolving needs of insurers, combining cutting-edge technology with deep industry expertise. For investors, Sapiens represents a compelling opportunity in the growing insurance technology (insurtech) space, with a strong track record of innovation and customer satisfaction.

Financially, Sapiens operates with a market capitalization of $1.534 billion USD, reflecting its established presence in the global market. The company’s price-to-earnings (P/E) ratio stands at 21.56, with a forward P/E of 29.59, indicating expectations for continued growth. The price-to-book (P/B) ratio of 3.27 and price-to-sales (P/S) ratio of 2.85 provide further insight into its valuation metrics, offering investors a data-driven perspective on its market position and potential.

Additional Sources for SPNS Stock

SPNS Stock Overview

Market Cap in USD 1,453m
Sector Technology
Industry Software - Application
GiC Sub-Industry Application Software
IPO / Inception 1992-05-29

SPNS Stock Ratings

Growth Rating -0.50
Fundamental 79.0
Dividend Rating 56.7
Rel. Strength -14
Analysts 2.8/5
Fair Price Momentum 25.25 USD
Fair Price DCF 19.11 USD

SPNS Dividends

Dividend Yield 12m 3.20%
Yield on Cost 5y 4.29%
Annual Growth 5y 32.42%
Payout Consistency 78.3%

SPNS Growth Ratios

Growth Correlation 3m 5.6%
Growth Correlation 12m -64.1%
Growth Correlation 5y 17.4%
CAGR 5y 4.28%
CAGR/Max DD 5y 0.08
Sharpe Ratio 12m 0.36
Alpha -19.09
Beta 0.942
Volatility 39.21%
Current Volume 189.2k
Average Volume 20d 145.1k
What is the price of SPNS stocks?
As of April 30, 2025, the stock is trading at USD 27.33 with a total of 189,228 shares traded.
Over the past week, the price has changed by +7.43%, over one month by +2.87%, over three months by +5.42% and over the past year by -10.23%.
Is Sapiens International a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Sapiens International (NASDAQ:SPNS) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 78.96 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SPNS as of April 2025 is 25.25. This means that SPNS is currently overvalued and has a potential downside of -7.61%.
Is SPNS a buy, sell or hold?
Sapiens International has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold SPNS.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 2
  • Sell: 2
  • Strong Sell: 0
What are the forecast for SPNS stock price target?
According to ValueRays Forecast Model, SPNS Sapiens International will be worth about 28.4 in April 2026. The stock is currently trading at 27.33. This means that the stock has a potential upside of +3.88%.
Issuer Forecast Upside
Wallstreet Target Price 29 6.1%
Analysts Target Price 29 6.1%
ValueRay Target Price 28.4 3.9%